Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REVVITY, INC. | 91,428 | reported | 29 Jan 2008 | tx 18+317,868−103,334 |
| Tempest Therapeutics, Inc. | 12,000 | reported | 04 Jul 2018 | tx 9+83,157 |
| Salarius Pharmaceuticals, Inc. | 12,000 | reported | 26 Jul 2017 | tx 4+52,000 |
| AGIOS PHARMACEUTICALS, INC. | 6,073 | reported | 20 Jun 2025 | tx 12+77,702−6,073 |
| NEOGEN CORP | 4,050 | reported | 27 Oct 2025 | tx 19+169,415−9,719 |
| BIOGEN INC. | 3,118 | reported | 12 Feb 2020 | tx 16+41,992−11,590 |
| BOSTON SCIENTIFIC CORP | 447 | reported | 27 Nov 2013 | tx 113+3,586,758−2,422,627 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Oct 2025 | EXERCISE | NEOGEN CORP | 1,777 | 6.19 USD | |
| 27 Oct 2025 | EXERCISE | NEOGEN CORP | 1,777 | 6.19 USD | deriv |
| 27 Oct 2025 | EXERCISE | NEOGEN CORP | 2,025 | 6.19 USD | |
| 27 Oct 2025 | EXERCISE | NEOGEN CORP | 2,025 | 6.19 USD | deriv |
| 23 Oct 2025 | GRANT_AWARD | NEOGEN CORP | 19,769 | 6.07 USD | |
| 23 Oct 2025 | GRANT_AWARD | NEOGEN CORP | 50,814 | 0.00 USD | deriv |
| 07 Oct 2025 | EXERCISE | NEOGEN CORP | 2,071 | 5.63 USD | |
| 07 Oct 2025 | EXERCISE | NEOGEN CORP | 2,071 | 5.63 USD | deriv |
| 20 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 2,861 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 15,768 | 0.00 USD | deriv |
| 20 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | deriv |
| 13 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,977 | 0.00 USD | |
| 13 Jun 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,977 | 0.00 USD | deriv |
| 22 Apr 2025 | PURCHASE | NEOGEN CORP | 20,712 | 4.84 USD | first after silence |
| 28 Oct 2024 | EXERCISE | NEOGEN CORP | 1,776 | 13.81 USD | |
| 28 Oct 2024 | EXERCISE | NEOGEN CORP | 1,776 | 13.81 USD | deriv |
| 24 Oct 2024 | GRANT_AWARD | NEOGEN CORP | 6,075 | 13.58 USD | |
| 24 Oct 2024 | GRANT_AWARD | NEOGEN CORP | 18,653 | 0.00 USD | deriv |
| 07 Oct 2024 | EXERCISE | NEOGEN CORP | 2,070 | 15.07 USD | |
| 07 Oct 2024 | EXERCISE | NEOGEN CORP | 2,070 | 15.07 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 11,774 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | deriv |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,976 | 0.00 USD | |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,976 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 22 Apr 2025.